InvestorsHub Logo
Followers 0
Posts 320
Boards Moderated 0
Alias Born 05/17/2005

Re: VERYLONGSTOPPEDDRINKINGTHEKOOLAID post# 14384

Wednesday, 12/13/2006 8:02:05 AM

Wednesday, December 13, 2006 8:02:05 AM

Post# of 29237
Replies I irecieved from Medify:

Dear Investor

Thank you for your recent communication.

We hope the information supplied below answers your queries.

1. What is the company doing to get more publicity so as to get more investors interested in the stock or at least know that it exists?

A strategic marketing plan has been developed in order to address both Investor (new and current) PR along with a commercial product marketing plan. This strategy is designed to increase awareness of Medify Solutions and MedifyRemote to both potential investors and the target market for the product.

The objective of the implementation of a strategic marketing platform is to increase revenue and deliver long-term growth and stability for the share price.

2. It has been rumored that the company is re-evaluating the issuing of the additional 33 million restricted shares which has further diluted the shareholders value. Is this true?

The board is actively reviewing the restricted share situation.

3. With revenues starting to come in shortly will the be a need for additional 504 stock sales?

The management and board are committed to delivering strong revenue growth, and the interest in MedifyRemote and the rapidly expanding sales pipeline support this commitment. Obviously there are ongoing costs associated with the continuing operation of the company and these must be supported. It is our hope that incoming revenues will fully support this activity at the earliest possible opportunity.

Thank you for your continued communication and support.

Best Regards

Investor Relations
Medify Solutions Limited

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.